"Factor VIII" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin.
| Descriptor ID |
D005169
|
| MeSH Number(s) |
D12.776.124.125.350 D23.119.350
|
| Concept/Terms |
Factor VIII- Factor VIII
- Factor 8
- Coagulation Factor VIII
- Thromboplastinogen
- Blood Coagulation Factor VIII
- Factor Eight
Hyatt-C- Hyatt-C
- Hyatt C
- HyattC
- Hyate-C
- Hyate C
- HyateC
|
Below are MeSH descriptors whose meaning is more general than "Factor VIII".
Below are MeSH descriptors whose meaning is more specific than "Factor VIII".
This graph shows the total number of publications written about "Factor VIII" by people in this website by year, and whether "Factor VIII" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 17 | 9 | 26 |
| 2018 | 13 | 7 | 20 |
| 2019 | 5 | 3 | 8 |
| 2020 | 3 | 5 | 8 |
| 2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Factor VIII" by people in Profiles.
-
Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey. Haemophilia. 2021 Sep; 27(5):736-743.
-
Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study. Blood Coagul Fibrinolysis. 2021 Jun 01; 32(4):285-289.
-
A case report of acquired hemophilia following COVID-19 vaccine. J Thromb Haemost. 2021 06; 19(6):1515-1518.
-
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia. Hamostaseologie. 2021 Jun; 41(3):190-196.
-
COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management. Shock. 2021 04 01; 55(4):465-471.
-
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021 02 09; 5(3):756-759.
-
Management of COVID-19-associated coagulopathy in persons with haemophilia. Haemophilia. 2021 Jan; 27(1):41-48.
-
An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor. Am J Case Rep. 2020 Oct 30; 21:e926728.
-
Blood component use in critical care in patients with COVID-19 infection: a single-centre experience. Br J Haematol. 2020 Nov; 191(3):382-385.
-
Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A. Acta Haematol. 2021; 144(3):319-321.